Results 1 to 1 of 1 matches
Category 6 - PATHOLOGY SERVICES
73304 - Additional Information
Item Start Date:
01-Apr-2022
Description Updated:
01-Apr-2022
Schedule Fee Updated:
01-Apr-2022
Group
P7 - Genetics
Detection of germline BRCA1 or BRCA2 pathogenic or likely pathogenic gene variants, in a patient with metastatic castration‑resistant prostate cancer, for whom testing of tumour tissue is not clinically feasible, requested by a specialist or consultant physician, to determine eligibility for olaparib under the Pharmaceutical Benefits Scheme.
Applicable once per lifetime
Fee: $1,000.00 Benefit: 75% = $750.00 85% = $901.30
(See para PN.0.23 of explanatory notes to this Category)
Results 1 to 1 of 1 matches
Legend
- Assist - Addition/Deletion of (Assist.)
- Amend - Amended Description
- Anaes - Anaesthetic Values Amended
- Emsn - EMSN Change
- Fee - Fee Amended
- Renum - Item Number Change (renumbered)
- New - New Item
- NewMin - New Item (previous Ministerial Determination)
- Qfe - QFE Change